Sang-Moo Kang, Lizheng Guo, Qizhi Yao, Ioanna Skountzou, and Richard W. Compans. Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens. J. Virol., Sep 2004; 78: 9624 - 9632
Intranasal Immunization with Inactivated Influenza Virus Enhances Immune Responses to Coadministered Simian-Human Immunodeficiency Virus-Like Particle Antigens
Sang-Moo Kang,1,
Lizheng Guo,1,
Qizhi Yao,2 Ioanna Skountzou,1 and Richard W. Compans1*
Department of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia,1 Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas2
Received 28 January 2004/ Accepted 27 April 2004
Intranasal immunization with inactivated influenza virus vaccine can provide protective immunity, whereas many other antigens are less effective when used for mucosal immunization. To determine whether influenza virus could enhance immune responses to an antigen coadministered to a mucosal surface, we studied the intranasal immunization of mice with a mixture of simian-human immunodeficiency virus (SHIV) virus-like particles (VLPs) and inactivated influenza virus. Compared to mice immunized with SHIV VLPs alone, mice coimmunized with SHIV VLPs and inactivated influenza virus showed significant increases in serum immunoglobulin G (IgG) and mucosal IgA antibodies specific to the human immunodeficiency virus envelope protein, neutralizing activities, numbers of gamma interferon- and interleukin 4-secreting lymphocytes, and cytotoxic-T-lymphocyte activities. The levels of enhancement of immune response by coimmunization with inactivated influenza virus were equivalent to those induced by inclusion of immunostimulatory CpG oligodeoxynucleotides (CpG DNA). We also observed that SHIV VLPs bind to influenza virus virions, forming mixed aggregates. These results indicate that inactivated influenza virus can play a role as a mucosal adjuvant to coadministered antigens.
* Corresponding author. Mailing address: Department of Microbiology and Immunology, Emory University School of Medicine, 1510 Clifton Rd., Atlanta, GA 30322. Phone: (404) 727-5947. Fax: (404) 727-8250. E-mail: compans@microbio.emory.edu.
See Also:
Latest articles in those days:
- Zoonotic infections and genomic evolution of novel reassortant swine influenza A viruses in Spain 20 hours ago
- Highly Pathogenic Avian Influenza H5N1 in a Commercial Turkey Breeder Farm with Structured Entry Biosecurity: A Descriptive Field Investigation 20 hours ago
- Spread of H5N1 Avian Influenza Viruses Clade 2.3.4.4b in the Russian Federation, 2021-2023 20 hours ago
- Update to the CDC influenza A(H3) subtyping assay for improved detection of influenza A(H3N2) viruses, including subclade K viruses 20 hours ago
- Bovine myxovirus resistance protein (Mx)1, but not Mx2, mediates antiviral activity against human and avian influenza A viruses, including H5N1 clade 2.3.4.4b 21 hours ago
[Go Top] [Close Window]



Contributed equally to this study.